Stock MEDICAMEQ MEDICAMEN BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medicamen Biotech Limited

Equities

MEDICAMEQ

INE646B01010

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 12:03:37 16/05/2024 pm IST 		5-day change 1st Jan Change
499.1 INR +0.86% Intraday chart for Medicamen Biotech Limited -4.76% -17.86%
12/02 Medicamen Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Medicamen Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 6,971 5,673 2,208 6,524 7,864 8,293
Enterprise Value (EV) 1 6,889 5,706 2,291 6,673 8,084 8,343
P/E ratio 66 x 47.2 x 16.5 x 53.8 x 52.8 x 55 x
Yield 0.17% 0.21% 0.28% 0.19% 0.16% 0.15%
Capitalization / Revenue 6.25 x 4.62 x 1.76 x 5.79 x 6.81 x 5.89 x
EV / Revenue 6.18 x 4.65 x 1.83 x 5.92 x 7 x 5.92 x
EV / EBITDA 41.6 x 33.2 x 11.9 x 34.6 x 34.3 x 34.9 x
EV / FCF -40.2 x -40.5 x -8.25 x -208 x -95.2 x -96.5 x
FCF Yield -2.49% -2.47% -12.1% -0.48% -1.05% -1.04%
Price to Book 9.34 x 6.55 x 1.82 x 4.91 x 5.37 x 4.29 x
Nbr of stocks (in thousands) 11,700 11,700 12,217 12,217 12,217 12,651
Reference price 2 595.8 484.9 180.7 534.0 643.7 655.6
Announcement Date 11/09/18 31/08/19 04/09/20 02/09/21 03/09/22 02/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 1,115 1,227 1,255 1,127 1,154 1,409
EBITDA 1 165.6 171.9 192.5 192.8 235.7 238.9
EBIT 1 145.5 150.3 168.2 168.3 179 176.3
Operating Margin 13.04% 12.25% 13.4% 14.93% 15.5% 12.52%
Earnings before Tax (EBT) 1 139 175.2 179.8 163.9 180.9 170.4
Net income 1 101.1 120.3 132.9 121.3 149 148.4
Net margin 9.07% 9.8% 10.59% 10.76% 12.9% 10.54%
EPS 2 9.030 10.28 10.94 9.930 12.19 11.92
Free Cash Flow 1 -171.3 -141 -277.8 -32.11 -84.89 -86.46
FCF margin -15.36% -11.49% -22.13% -2.85% -7.35% -6.14%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 1.000 1.000 0.5000 1.000 1.000 1.000
Announcement Date 11/09/18 31/08/19 04/09/20 02/09/21 03/09/22 02/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - 32.4 83.8 149 220 49.3
Net Cash position 1 82.4 - - - - -
Leverage (Debt/EBITDA) - 0.1882 x 0.4351 x 0.7743 x 0.9323 x 0.2064 x
Free Cash Flow 1 -171 -141 -278 -32.1 -84.9 -86.5
ROE (net income / shareholders' equity) 19.9% 14.9% 12.8% 9.55% 10.7% 8.67%
ROA (Net income/ Total Assets) 9.52% 7.39% 6.61% 5.6% 5.33% 4.37%
Assets 1 1,062 1,626 2,009 2,164 2,793 3,396
Book Value Per Share 2 63.80 74.00 99.20 109.0 120.0 153.0
Cash Flow per Share 2 19.40 7.280 2.530 3.180 3.130 16.40
Capex 1 81.9 157 376 180 86.1 66
Capex / Sales 7.34% 12.78% 29.96% 15.94% 7.46% 4.69%
Announcement Date 11/09/18 31/08/19 04/09/20 02/09/21 03/09/22 02/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
MEDICAMEN BIOTECH LIMITED Stock Medicamen Biotech Limited
-17.86% 7.54Cr
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.28% 4.39TCr
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+24.47% 2.31TCr
SANDOZ GROUP AG Stock Sandoz Group AG
+19.22% 1.53TCr
CIPLA LIMITED Stock Cipla Limited
+12.87% 1.36TCr
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.67% 1.2TCr
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.92% 699.72Cr
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 678.76Cr
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.07% 559.68Cr
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MEDICAMEQ Stock
  4. Financials Medicamen Biotech Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW